Literature DB >> 18982248

Meal-induced acceleration of tablet transit through the human small intestine.

Hala M Fadda1, Emma L McConnell, Michael D Short, Abdul W Basit.   

Abstract

PURPOSE: The transit of dosage forms through the small intestine is considered to be constant at around 3 h, and unaffected by the presence of food. Here we address this assumption and examine how the timing of tablet and food administration can influence small intestine transit time.
METHODS: A non-disintegrating, radiolabelled tablet was given to ten healthy volunteers in a three-way crossover study using three different feeding regimens (1) fasted (tablet administered on an empty stomach and food withheld for four hours) (2) fed (tablet administered after food) and (3) pre-feed (tablet administered 45 min before food). Tablet transit through the gastrointestinal tract was followed using gamma scintigraphy.
RESULTS: The small intestinal transit times of tablets after fasted and fed dosing regimens were similar, median 204 and 210 min respectively. With the pre-feed dose, small intestinal transit time was significantly shorter than in the fasted or fed state at 141 min. With this dosing regimen, in six of the volunteers tablets were in the upper small intestine when food arrived and these had a median small intestinal transit time of 100 min.
CONCLUSIONS: The timing of food ingestion has a clear effect on small intestinal transit of single-unit formulations and this has implications for drug bioavailability.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18982248     DOI: 10.1007/s11095-008-9749-2

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  30 in total

1.  Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.

Authors:  Valentine C Ibekwe; Hala M Fadda; Emma L McConnell; Mandeep K Khela; David F Evans; Abdul W Basit
Journal:  Pharm Res       Date:  2008-05-09       Impact factor: 4.200

2.  Transit of pharmaceutical dosage forms through the small intestine.

Authors:  S S Davis; J G Hardy; J W Fara
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

3.  Effects of cholecystokinin and metoclopramide on jejunal movements of water and electrolytes and on transit time of luminal fluid in man.

Authors:  C Matuchansky; P M Huet; J Y Mary; J C Rambaud; J J Bernier
Journal:  Eur J Clin Invest       Date:  1972-03       Impact factor: 4.686

4.  The effect of eating on transit through the small intestine.

Authors:  M J Mundy; C G Wilson; J G Hardy
Journal:  Nucl Med Commun       Date:  1989-01       Impact factor: 1.690

Review 5.  Prokinetic agents: a key in the future of gastroenterology.

Authors:  J C Reynolds
Journal:  Gastroenterol Clin North Am       Date:  1989-06       Impact factor: 3.806

6.  Gamma scintigraphic evaluation of film-coated tablets intended for colonic or biphasic release.

Authors:  Kwabena Ofori-Kwakye; John T Fell; Harbans L Sharma; Anne-Marie Smith
Journal:  Int J Pharm       Date:  2004-02-11       Impact factor: 5.875

7.  Concentration-dependent effects of polyethylene glycol 400 on gastrointestinal transit and drug absorption.

Authors:  Julia D R Schulze; Wendy A Waddington; Peter J Eli; Gary E Parsons; Mark D Coffin; Abdul W Basit
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

8.  The effect of oleic acid on the human ileal brake and its implications for small intestinal transit of tablet formulations.

Authors:  C L Dobson; S S Davis; S Chauhan; R A Sparrow; I R Wilding
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

9.  Neutron activation based gamma scintigraphic evaluation of enteric-coated capsules for local treatment in colon.

Authors:  Tuuli Marvola; Janne Marvola; Hanna Kanerva; Aapo Ahonen; Kai Lindevall; Martti Marvola
Journal:  Int J Pharm       Date:  2007-08-02       Impact factor: 5.875

10.  Human interdigestive motility: variations in patterns from esophagus to colon.

Authors:  J E Kellow; T J Borody; S F Phillips; R L Tucker; A C Haddad
Journal:  Gastroenterology       Date:  1986-08       Impact factor: 22.682

View more
  9 in total

1.  Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions.

Authors:  Emilie Hénin; Martin Bergstrand; Werner Weitschies; Mats O Karlsson
Journal:  Pharm Res       Date:  2015-11-09       Impact factor: 4.200

2.  Mathematical Models to Explore Potential Effects of Supersaturation and Precipitation on Oral Bioavailability of Poorly Soluble Drugs.

Authors:  Mary S Kleppe; Kelly M Forney-Stevens; Roy J Haskell; Robin H Bogner
Journal:  AAPS J       Date:  2015-04-08       Impact factor: 4.009

3.  Meta-analysis of oro-cecal transit time in fasting subjects.

Authors:  Tohru Kokubo; Shigeyuki Matsui; Makio Ishiguro
Journal:  Pharm Res       Date:  2012-09-28       Impact factor: 4.200

Review 4.  A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption-Part II: Gastrointestinal Transit Time.

Authors:  Ahmad Y Abuhelwa; David J R Foster; Richard N Upton
Journal:  AAPS J       Date:  2016-07-20       Impact factor: 4.009

Review 5.  Population-based mechanistic prediction of oral drug absorption.

Authors:  Masoud Jamei; David Turner; Jiansong Yang; Sibylle Neuhoff; Sebastian Polak; Amin Rostami-Hodjegan; Geoffrey Tucker
Journal:  AAPS J       Date:  2009-04-21       Impact factor: 4.009

Review 6.  Influence of Food on Paediatric Gastrointestinal Drug Absorption Following Oral Administration: A Review.

Authors:  Hannah K Batchelor
Journal:  Children (Basel)       Date:  2015-06-09

Review 7.  Nutritional strategies to attenuate postprandial glycemic response.

Authors:  Kenneth Pasmans; Ruth C R Meex; Luc J C van Loon; Ellen E Blaak
Journal:  Obes Rev       Date:  2022-06-10       Impact factor: 10.867

8.  Exploration of Neusilin® US2 as an Acceptable Filler in HPMC Matrix Systems-Comparison of Pharmacopoeial and Dynamic Biorelevant Dissolution Study.

Authors:  Tomáš Bílik; Jakub Vysloužil; Martina Naiserová; Jan Muselík; Miroslava Pavelková; Josef Mašek; Drahomíra Čopová; Martin Čulen; Kateřina Kubová
Journal:  Pharmaceutics       Date:  2022-01-05       Impact factor: 6.321

9.  The Effect of Capsule-in-Capsule Combinations on In Vivo Disintegration in Human Volunteers: A Combined Imaging and Salivary Tracer Study.

Authors:  Adrian Rump; Franziska N Weiss; Louisa Schulz; Marie-Luise Kromrey; Eberhard Scheuch; Mladen V Tzvetkov; Tyler White; Shane Durkee; Kevin W Judge; Vincent Jannin; Aouatef Bellamine; Werner Weitschies; Michael Grimm
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.